TEM:NSD-Tempus AI, Inc. Class A Common Stock (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 49.23

Change

-5.44 (-9.95)%

Market Cap

N/A

Volume

2.00M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+1.74 (+2.00%)

USD 39.63B
HQY HealthEquity Inc

-1.26 (-1.60%)

USD 6.83B
RCM R1 RCM Inc

+0.02 (+0.14%)

USD 5.96B
GDRX Goodrx Holdings Inc

-0.24 (-3.16%)

USD 2.94B
BTSG BrightSpring Health Services, ..

+0.23 (+1.57%)

USD 2.37B
PRVA Privia Health Group Inc

+0.27 (+1.44%)

USD 2.23B
PINC Premier Inc

-0.05 (-0.24%)

USD 2.03B
OMCL Omnicell Inc

-2.14 (-4.76%)

USD 1.99B
CERT Certara Inc

+0.10 (+0.92%)

USD 1.76B
SDGR Schrodinger Inc

+0.10 (+0.51%)

USD 1.48B

ETFs Containing TEM

REMX VanEck Rare Earth/Strateg.. 5.49 % 0.59 %

-0.46 (0%)

N/A
SPXZ 1.50 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector